{"result": "(\"entity\"<|>DEHIDROEPIANDROSTERONA<|>EVENT<|>Dehidroepiandrosterona is a hormone whose administration has shown contradictory results in studies regarding its effects on postmenopausal women and exercise interventions.)\n##\n(\"entity\"<|>EJERCICIO FÍSICO<|>EVENT<|>Ejercicio físico refers to physical exercise interventions that have been studied for their benefits on aging and frailty.)\n##\n(\"entity\"<|>HORMONA DE CRECIMIENTO<|>EVENT<|>Hormona de crecimiento is a treatment that has shown effectiveness in clinical trials for both deficient and non-deficient subjects.)\n##\n(\"entity\"<|>TIBOLONA<|>EVENT<|>Tibolona is a hormonal compound that has shown medium-term benefits in increasing strength and reducing fat mass in frail elderly individuals.)\n##\n(\"entity\"<|>ANDRÓGENOS<|>EVENT<|>Andrógenos are hormones that have been studied for their effects on muscle strength and mass, with various synthetic modulators being tested.)\n##\n(\"entity\"<|>ESTRÓGENOS<|>EVENT<|>Estrógenos are hormones that have been evaluated for their impact on muscle strength in postmenopausal women, with mixed results.)\n##\n(\"entity\"<|>SARCOPENIA<|>EVENT<|>Sarcopenia is a condition associated with muscle loss that has been linked to hormonal treatments and exercise interventions.)\n##\n(\"entity\"<|>MMA<|>EVENT<|>MME refers to the measure of muscle mass and strength, which is crucial for maintaining independence in daily activities among the elderly.)\n##\n(\"relationship\"<|>DEHIDROEPIANDROSTERONA<|>EJERCICIO FÍSICO<|>Dehidroepiandrosterona has been studied in conjunction with exercise interventions to assess its effectiveness in postmenopausal women<|>5)\n##\n(\"relationship\"<|>HORMONA DE CRECIMIENTO<|>EJERCICIO FÍSICO<|>Hormona de crecimiento treatment has been evaluated alongside exercise interventions for its effects on muscle strength<|>5)\n##\n(\"relationship\"<|>TIBOLONA<|>EJERCICIO FÍSICO<|>Tibolona has been shown to have positive effects on strength when combined with exercise in frail elderly individuals<|>6)\n##\n(\"relationship\"<|>ANDRÓGENOS<|>EJERCICIO FÍSICO<|>Andrógenos have been studied for their impact on muscle strength and mass in relation to exercise<|>5)\n##\n(\"relationship\"<|>ESTRÓGENOS<|>EJERCICIO FÍSICO<|>Estrógenos have been evaluated for their effects on muscle strength in conjunction with physical activity<|>5)\n##\n(\"relationship\"<|>SARCOPENIA<|>EJERCICIO FÍSICO<|>Sarcopenia is a condition that has been linked to the effectiveness of exercise interventions in elderly populations<|>6)\n##\n(\"relationship\"<|>MME<|>EJERCICIO FÍSICO<|>MME is a critical measure that is influenced by exercise interventions aimed at improving physical performance<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ado resultados pro-\nminuidas, y cifras de testosterona plasmática inequívo-             metedores, pero aún no concluyentes, son: inhibidores\ncamente bajas, deberían tratarse, aunque una ausencia               de la enzima convertidora de angiotensina (ensayos\nde mejoría en los 4-6 meses siguientes, debería hacer               clínicos con perindopril y fosinopril han ofrecido datos\nconsiderar la retirada. Es bien conocido el hecho de que            contradictorios con respecto a la capacidad funcional y\nlos varones obesos tienen niveles más bajos de testoste-            a la fuerza muscular), bloqueantes de la miostatina –\nrona, pero no hay ensayos clínicos que evalúen el trata-            regulador negativo de la masa muscular, sintetizado\nmiento hormonal sustitutivo si se asocia sarcopenia.                en tejidos adiposo y muscular– (folistatina, trichostati-\nOtros fármacos ensayados en este sentido han sido los               na   A,   anticuerpos      recombinantes         anti-miostatina),\nmoduladores sintéticos de andrógenos (nortestostero-                factores de crecimiento IGF-1 y factor de crecimiento\nna) o los moduladores selectivos de los receptores de               mecánico, factor neutrofílico ciliar, agentes antiinfla-\nandrógenos (ostarina), que tiene efectos probados so-               matorios (ácidos grasos omega-3, inhibidores de la ci-\nbre el músculo –en modelos animales-, pero carecen de               clooxigenasa), creatina, bicarbonato, Ginkgo biloba,\nlos efectos negativos de los andrógenos54.                          coenzima Q y agonistas de receptores β.\n   Dehidroepiandrosterona:             Los   estudios     muestran  4.3.   Intervención sobre el ejercicio físico\nresultados contradictorios. Así, la administración de\n50 mg/día durante 12 semanas en mujeres postme-                       Los beneficios del ejercicio físico en el envejecimien-\nnopáusicas, combinado con ejercicios contra resisten-               to, y específicamente en la fragilidad, han sido objeto\ncia, no muestra beneficios adicionales a corto plazo.               de investigación científica reciente. Las intervenciones\nTampoco a largo plazo en varones y mujeres con nive-                de ejercicio parecen desempeñar un papel sobre la\nles normales o bajos, mientras que dosis más elevadas               fuerza muscular y la mejora del rendimiento físico,\nde 100 mg/día durante 6 meses podrían aumentar la                   aunque     no    parecen     aumentar      consistentemente         la\nMME en varones, pero no en mujeres55.                               MME en las personas ancianas frágiles y sedentarias\n                                                                    que viven en la comunidad10. También se ha compro-\n   Estrógenos: La mayoría de los estudios realizados en             bado cómo un nivel de actividad física alto en el ancia-\nmujeres postmenopáusicas apuntan a que la sustitu-                  no, se ha asociado con una disminución del riesgo de\nción estrogénica no aumenta la fuerza muscular a cor-               mortalidad,     enfermedades         crónicas,    institucionaliza-\nto (resultados discordantes en fuerza muscular, masa                ción y deterioro cognitivo y funcional. De manera más\nmagra y en masa grasa) ni largo plazo. La tibolona, un              concreta, el tipo de ejercicio más beneficioso en el an-\ncompuesto de perfil hormonal estrogénico, progestá-                 ciano frágil es el denominado entrenamiento multi-\ngeno y androgénico, ha mostrado a medio plazo, a                    componente. Este tipo de programas combinan entre-\ndosis de 2,5 mg/día, un aumento en la fuerza de pren-               namiento de fuerza, resistencia, equilibrio y marcha, y\nsión, de la masa magra, y posiblemente también re-                  se han mostrado eficaces en la mejoría de la capacidad\nducción de la masa grasa. No obstante, si se elige de               funcional, que es un elemento fundamental para el\nforma apropiada la población diana, el tratamiento                  mantenimiento de la independencia en las actividades\nhormonal sustitutivo podría prevenir o revertir la pérdi-           básicas de la vida diaria de los ancianos58. Incluyen:\nda de MME y el descenso de la función física56.\n                                                                      Ejercicio de fuerza muscular (o contra resistencia):\n   Hormona de crecimiento (GH):              En ensayos clínicos,   Consiste en la realización de contracciones dinámicas o\nel tratamiento con hormona de crecimiento, tanto en                 estáticas contra una resistencia: con pesas, con máqui-\nsujetos con deficiencia como sin ella, ha demostrado                nas de resistencia o con c\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}